Unveiling the mechanisms and challenges of cancer drug resistance
Cancer treatment faces many hurdles and resistance is one among them. Anti-cancer
treatment strategies are evolving due to innate and acquired resistance capacity, governed …
treatment strategies are evolving due to innate and acquired resistance capacity, governed …
Recent advances in the anticancer applications of benzimidazole derivatives
Cancer, one of the most deadly diseases worldwide, is still a crucial challenge to human
well‐being. Hence, the design and development of modern protocols to cure diverse kinds …
well‐being. Hence, the design and development of modern protocols to cure diverse kinds …
[HTML][HTML] S-Nitrosylation at the intersection of metabolism and autophagy: Implications for cancer
S Guil-Luna, MT Sanchez-Montero… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Metabolic plasticity, which determines tumour growth and metastasis, is now understood to
be a flexible and context-specific process in cancer metabolism. One of the major pathways …
be a flexible and context-specific process in cancer metabolism. One of the major pathways …
Design, synthesis and antiproliferative screening of newly synthesized acrylate derivatives as potential anticancer agents
DS Alshaya, RMO Tawakul, I Zaki, AHA Almaaty… - RSC …, 2023 - pubs.rsc.org
A new series of acrylic acid and acrylate ester derivatives as modified analogs of tubulin
polymerization inhibitors were designed and synthesized. The antiproliferative activity of the …
polymerization inhibitors were designed and synthesized. The antiproliferative activity of the …
[HTML][HTML] OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1/2 MAPK signaling in lung adenocarcinoma
Y Wang, L Shi, Y He, W Gong, Y Cui, R Zuo, Y Wang… - Iscience, 2024 - cell.com
Lung adenocarcinoma (LUAD) is one of the leading causes of cancer-related death
worldwide. Epithelial-mesenchymal transition (EMT) plays an important role in malignant …
worldwide. Epithelial-mesenchymal transition (EMT) plays an important role in malignant …
Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment
NI Agalakova - International Journal of Molecular Sciences, 2024 - mdpi.com
Chloroquine (CQ) and its derivate hydroxychloroquine (HCQ), the compounds with
recognized ability to suppress autophagy, have been tested in experimental works and in …
recognized ability to suppress autophagy, have been tested in experimental works and in …
Autoimmunity and Carcinogenesis: Their Relationship under the Umbrella of Autophagy
G Műzes, F Sipos - Biomedicines, 2023 - mdpi.com
The immune system and autophagy share a functional relationship. Both innate and
adaptive immune responses involve autophagy and, depending on the disease's origin and …
adaptive immune responses involve autophagy and, depending on the disease's origin and …
Synthesis, Cytotoxic Activity, Docking and MD Simulation of N,N‐Disubstituted New Benzimidazolium Salts
Novel N, N‐disubstituted benzimidazolium salts were efficaciously synthesized in moderate
to high yields and identified via 1H NMR and 13C NMR analyses. These compounds were …
to high yields and identified via 1H NMR and 13C NMR analyses. These compounds were …
Britannin suppresses MCF-7 breast cancer cell growth by inducing apoptosis and inhibiting autophagy.
Objective: Breast cancer is the main reason for cancer-related death in women. Britannin is
a sesquiterpene lactone compound derived from Inula aucheriana with anti-tumor …
a sesquiterpene lactone compound derived from Inula aucheriana with anti-tumor …
Hydroxychloroquine had neutral effect on long‐term risk of malignancy in rheumatoid arthritis patients: A population‐based retrospective cohort study
XJ Hou, R Chang, YH Wang, TL Kang… - International Journal of …, 2024 - Wiley Online Library
Background The cancer risk in rheumatoid arthritis (RA) patients has been discussed.
Hydroxychloroquine (HCQ) may exert protective effects against malignancy. The study …
Hydroxychloroquine (HCQ) may exert protective effects against malignancy. The study …